Novartis lifts 2023 earnings forecast for third time

  • 📰 Reuters
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 97%

Business News News

Business Business Latest News,Business Business Headlines

Switzerland's Novartis (NOVN.S) on Tuesday raised its full-year earnings forecast for the third time, citing cost cuts and higher-than-forecast prices for a multiple sclerosis (MS) drug.

The company's logo is seen at a building of Swiss drugmaker Novartis in Rotkreuz, Switzerland, January 29, 2020. REUTERS/Arnd Wiegmann/File photoon Tuesday raised its full-year earnings forecast for the third time, citing cost cuts and higher-than-forecast prices for a multiple sclerosis drug.on Oct.

Having come under investor pressure to deliver more development milestones, he scored a major win this year when breast cancer drugFaster-than-planned efficiency gains from the job cuts and more benign cost inflation contributed to the improved outlook, said Chief Financial Officer Harry Kirsch. Third-quarter group sales rose 12% to $11.78 billion, excluding contributions from Sandoz, above an analyst consensus of $11.25 billion provided by the company.

Among products driving the performance, revenues from psoriasis and arthritis drug Cosentyx gained 4% to a better-than-expected $1.33 billion.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in BUSÄ°NESS

Business Business Latest News, Business Business Headlines